ARCHIVES

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Plans Phase-Out Of K04 Career Awards

March 3, 1995

NIH May Claim BRCA1 Rights, While Myriad Files For Patent

October 7, 1994

In Brief: A Third Of Smokers Quit For Smokeout-Gallup; 77 Percent Pass Oncology Nursing Examination

November 23, 1990

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002

Cooperative Groups Meet With NCI to Discuss Plan to use Rosenberg’s Regimen At Member Institutions

December 13, 1985

Other Contract Concepts Approved By DCE Board

March 10, 1989